Adherence to gout treatment guidelines in patients with diabetes: A Danish prospective cohort study with 4 years of follow-up
Primary Care Diabetes · 2025
DOI: 10.1016/j.pcd.2025.08.006 ↗Kurz gefasst
Leitlinie in der Zeitschrift Primary Care Diabetes, 2025. Verfasst von Claus Rasmussen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, North Denmark Regional Hospital, Hjørring, Denmark; Center for Clinical Research, North Denmark Regional Hospital, Hjørri…. Hauptthemen laut MEDLINE: Gout, Guideline Adherence, Gout Suppressants, Practice Guidelines as Topic. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
AIMS: Diabetes affects about 6 % of the global population, with 20 % developing foot ulcers. Gout impacts approximately 3 %, but fewer than 40 % receive adequate urate-lowering therapy to prevent or dissolve tophi in the feet. This study assessed adherence to recommended gout treatment in patients with diabetes. METHODS: From a prospective cohort of gout patients, confirmed by microscopy-identified urate crystals, we identified those with concomitant diabetes. Patients were treated in various real-life healthcare settings. The primary outcome was achieving target serum urate levels four years post-diagnosis: < 0.36 mmol/L for general gout management and < 0.30 mmol/L for tophi patients. RESULTS: Of 286 gout patients, 85 (30 %) had diabetes. The median age was 71 years, and 76 % were male, with common comorbidities. Urate levels sufficient to prevent new tophi were maintained by 58 %. However, 45 % had tophi at diagnosis, and only 46 % of these achieved levels low enough to dissolve tophi. CONCLUSIONS: Gout in patients with diabetes is often inadequately managed, potentially leading to persistent tophi, which may ulcerate and contribute to foot ulcers. These findings likely reflect typical treatment settings. Affordable and effective gout treatment could prevent tophi formation and improve outcomes. Consideration of gout screening in diabetes management guidelines is recommended.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, North Denmark Regional Hospital, Hjørring, Denmark; Center for Clinical Research, North Denmark Regional Hospital, Hjørring, Denmark; Department of Clinical Biochemistry, North Denmark Region…
- Department of Rheumatology, North Denmark Regional Hospital, Hjørring, Denmark; Center for Clinical Research, North Denmark Regional Hospital, Hjørring, Denmark. Electronic address: jwn@rn.dk.
- Department Endocrinology, Aalborg University Hospital, Aalborg, Denmark. Electronic address: p.holm@rn.dk.
- Department of Clinical Biochemistry, North Denmark Regional Hospital, Hjørring, Denmark. Electronic address: sotj@rn.dk.
- Department of Clinical Medicine, Aalborg University, Aalborg, Denmark; Department of Internal Medicine, Farsø Outpatient Clinic, Aalborg University Hospital, Aalborg, Denmark. Electronic address: guln@rn.dk.
Zitieren
APA
Rasmussen, C., Larsen, J. W., Holm, P. C. W., Jepsen, S. T., & Nielsen, G. L. (2025). Adherence to gout treatment guidelines in patients with diabetes: A Danish prospective cohort study with 4 years of follow-up. Primary Care Diabetes. https://doi.org/10.1016/j.pcd.2025.08.006
Vancouver
Rasmussen C, Larsen JW, Holm PCW, Jepsen ST, Nielsen GL. Adherence to gout treatment guidelines in patients with diabetes: A Danish prospective cohort study with 4 years of follow-up. Primary Care Diabetes. 2025. doi:10.1016/j.pcd.2025.08.006
BibTeX
@article{Rasmussen2025,
author = {Rasmussen, Claus and Larsen, Jesper Walther and Holm, Peter Clement Waldhauer and Jepsen, Søren Terpager and Nielsen, Gunnar Lauge},
title = {Adherence to gout treatment guidelines in patients with diabetes: A Danish prospective cohort study with 4 years of follow-up},
journal = {Primary Care Diabetes},
year = {2025},
doi = {10.1016/j.pcd.2025.08.006}
}
EUVIMED